Cannabis Biotech Companies are Selling High On the Stock Market

The success of one weed-based drug trial sent investors scrambling to buy into the future of marijuana pharmaceuticals.

Stock brokers were left scratching their heads on Monday as the value of shares in a little-known company called Cannabis Science Inc. dramatically increased. By the end of day, they were up 120 percent.

The tiny Colorado-based biotech company, which has been quietly rallying to get FDA approval for its cannabis-based drugs since 2009, hadn’t done anything particularly newsworthy. In only released statement congratulating a fellow pot-friendly drug firm, the United Kingdom’s GW Pharmaceuticals, on its successful clinical trials for Epidolex, a cannabis-based child epilepsy drug. While it wasn’t much — it didn’t even have anything to do with the company — it was enough to send investors racing to buy Cannabis Science shares.

Thanks to the spread of the legalization...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.